Health care startups that raised Series A in Massachusetts, United States
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Remedium Bio | Needham | Series A | $10.0M | 2026-08-10 |
| Dash Bio | Boston | Series A | $30.0M | 2026-08-03 |
| InStockRx | Boston | Series A | $5.0M | 2026-07-01 |
| Xellar Biosystems | Newton | Series A | $29.5M | 2026-06-30 |
| EnVision Endoscopy | Lowell | Series A | $500K | 2026-03-30 |
| Coral Care | Boston | Series A | $13.0M | 2026-02-23 |
| Third Arc Bio | Boston | Series A | $52.0M | 2026-02-04 |
| AI Proteins | Boston | Series A | $42.5M | 2025-11-19 |
8 rows of the CSV in 5 of its 18 columns.
- The 308 health care startups in Massachusetts, United States whose last round is Series A have raised $12.3B in total.
- 31 of them closed their most recent round in the last 12 months, $1.2B combined.
- The largest of those rounds is Solstice Oncology's $225.0M Series A, dated September 2026.
- The most recent is Signet Therapeutics' $11.5M Series A on 4 November 2026.
- MassChallenge is an investor in 9 of them, more than any other fund.
- Biotech is the most common other sector, with 196 companies (64%).
- 36% were founded in 2020 or later; the median founding year is 2018.
- The most common team size is 11 to 50 employees (58% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
30 of 308| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Remedium Bio | Remedium Bio develops gene therapy treatments for various diseases. | Biotech | Needham | Series A | $10.0M | 2026-08-10 | $13.8M | National Science Foundation, MicroVentures, Longevitytech.fund +1 | 11 to 50 | 2020 |
| Dash Bio | Dash Bio develops automated laboratory workflows and software to support drug development through bioanalysis services. | Artificial intelligence | Boston | Series A | $30.0M | 2026-08-03 | $47.5M | Freestyle Capital, Swift Ventures, LifeX Ventures +1 | 11 to 50 | 2024 |
| InStockRx | InStockRx connects licensed pharmacies to buy and sell inventory with each other. | Commerce | Boston | Series A | $5.0M | 2026-07-01 | $5.1M | Techstars | 1 to 10 | 2020 |
| Xellar Biosystems | Xellar Biosystems analyzes drug testing and treatment data using artificial intelligence. | Artificial intelligence | Newton | Series A | $29.5M | 2026-06-30 | $93.2M | Legend Capital, Tiantu Capital, Zhengxuan Investment +1 | 11 to 50 | 2022 |
| EnVision Endoscopy | EnVision Endoscopy supplies medical devices and solutions used in endoscopic surgeries. | Health care | Lowell | Series A | $500K | 2026-03-30 | $3.9M | MassChallenge, National Science Foundation, MassVentures +1 | 1 to 10 | 2018 |
| Coral Care | Coral Care connects families with licensed speech, occupational, and physical therapists through a pediatric therapy platform. | Health care | Boston | Series A | $13.0M | 2026-02-23 | $19.5M | Hustle Fund, Reach Capital, AlleyCorp +2 | 11 to 50 | 2023 |
| Third Arc Bio | Third Arc Bio develops multifunctional antibodies for inflammatory and immunology diseases. | Biotech | Boston | Series A | $52.0M | 2026-02-04 | $217.0M | T. Rowe Price, Cormorant Asset Management, Foresite Capital +1 | 11 to 50 | 2022 |
| AI Proteins | AI Proteins designs and engineers miniprotein therapeutics using artificial intelligence. | Artificial intelligence | Boston | Series A | $42.5M | 2025-11-19 | $80.4M | Intel Ignite, Lightchain Capital, Cobro Ventures | 11 to 50 | 2021 |
| FamilyWell Health | FamilyWell Health provides integrated mental health services for pregnant and postpartum patients. | Health care | Boston | Series A | $8.0M | 2025-11-18 | $13.3M | .406 Ventures, GreyMatter, Springboard Enterprises +1 | 11 to 50 | 2022 |
| Folia Health | Folia Health is a platform that securely captures and shares users' health and symptom data. | Biotech | Boston | Series A | $10.5M | 2025-10-01 | $17.4M | MassChallenge, Social Starts, Bantam Group +2 | 11 to 50 | 2016 |
| Eyebot | Eyebot develops eye examination technology to expand access to quality vision care. | Artificial intelligence | Boston | Series A | $20.0M | 2025-08-26 | $29.9M | National Science Foundation, Village Global, MassVentures +2 | 11 to 50 | 2021 |
| Biobot Analytics | Biobot Analytics offers a wastewater data platform that delivers population-level health insights. | Artificial intelligence | Cambridge | Series A | $13.4M | 2025-06-06 | $41.4M | Y Combinator, Pioneer Fund, Soma Capital +2 | 11 to 50 | 2017 |
| PhaseV | PhaseV provides AI-driven solutions for clinical development and operations. | Artificial intelligence | Boston | Series A | $50.0M | 2025-05-13 | $65.0M | Viola Ventures, LionBird, GETTY +1 | 11 to 50 | 2023 |
| Lynx | Lynx provides an API-driven platform that lets businesses integrate healthcare financial services, payments, banking, and investments. | Fintech | Boston | Series A | $27.0M | 2025-02-06 | $44.5M | .406 Ventures, Obvious Ventures, Frist Cressey Ventures +2 | 11 to 50 | 2021 |
| ZETA SURGICAL | ZETA SURGICAL provides real-time frameless navigation for brain surgery, deployable beyond the operating room. | Artificial intelligence | Boston | Series A | $5.0M | 2025-01-21 | $13.9M | Y Combinator, Artesian VC, Brinc +2 | 11 to 50 | 2018 |
| Convergent Therapeutics | Convergent Therapeutics develops radiopharmaceutical therapies for prostate cancer. | Health care | Cambridge | Series A | $40.0M | 2024-09-24 | $130.0M | RA Capital Management, OrbiMed, Invus | 1 to 10 | 2021 |
| Axena Health | Axena Health develops commercial-stage medical devices for women's pelvic health. | Health care | Newton | Series A | $9.4M | 2024-06-04 | $36.2M | KOFA Healthcare, Avestria Ventures, Cross-Border Impact Ventures | 11 to 50 | 2023 |
| Progentos Therapeutics | Progentos Therapeutics develops a multiple sclerosis treatment that stimulates the body's natural repair mechanisms. | Biotech | Watertown | Series A | $65.0M | 2024-05-14 | $65.0M | Forbion Capital Partners, Dolby Family Ventures, Alta Partners +2 | 11 to 50 | 2023 |
| Nabla Bio | Nabla Bio uses an autoverse platform of biologically informed machine learning to co-develop antibody drugs. | Artificial intelligence | Cambridge | Series A | $26.0M | 2024-05-14 | $37.4M | Y Combinator, Khosla Ventures, National Science Foundation +2 | 11 to 50 | 2020 |
| MeaCor | MeaCor develops transcatheter devices for treating heart disease. | Health care | Ayer | Series A | $15.0M | 2024-05-14 | $15.0M | MedTech Innovator | 1 to 10 | 2015 |
| Opmed.ai | Opmed.ai provides technologies and services for hospitals and healthcare providers. | Health care | Boston | Series A | $15.0M | 2024-05-06 | $15.0M | NFX, Grove Ventures, Secret Chord Ventures +1 | 11 to 50 | 2020 |
| Delphia Therapeutics | Delphia Therapeutics operates a laboratory that develops treatments for cancer cells. | Health care | Cambridge | Series A | $67.0M | 2024-05-02 | $67.0M | Google Ventures, Polaris Partners, Alexandria Venture Investments +1 | 11 to 50 | 2022 |
| Adaptilens | Adaptilens develops an accommodating intraocular lens for cataract patients. | Biotech | Boston | Series A | $17.5M | 2024-04-29 | $19.1M | MassChallenge, Pillar VC, Perceptive Advisors +2 | 1 to 10 | 2019 |
| Corner Therapeutics | Corner Therapeutics conducts biotechnology research focused on immunotherapy. | Biotech | Watertown | Series A | $58.5M | 2024-04-18 | $58.5M | Bill & Melinda Gates Foundation, Ziff Capital Partners, Tanis ventures | 11 to 50 | 2020 |
| ZWI Therapeutics, Inc. | ZWI Therapeutics develops a polymer that reduces immunogenicity and improves protein therapeutic pharmacokinetics. | Health care | Watertown | Series A | $10.0M | 2024-01-24 | $20.0M | Sherpa Healthcare Partners | 1 to 10 | 2020 |
| Tome Biosciences | Tome Biosciences develops programmable gene insertion technology. | Biotech | Watertown | Series A | $213.0M | 2023-12-12 | $213.0M | Andreessen Horowitz, Google Ventures, Polaris Partners +1 | 101 to 250 | 2021 |
| Ascidian Therapeutics | Ascidian Therapeutics is a biotechnology company focused on medical and clinical gene therapy. | Biotech | Boston | Series A | $40.0M | 2023-11-08 | $90.0M | Apple Tree Partners | 11 to 50 | 2020 |
| ClinOne | ClinOne provides a clinical trial management solution with web and mobile access to trial details. | Health care | Needham | Series A | $2.0M | 2023-11-01 | $10.5M | Social Starts, Stout Street Capital, Rockies Venture Club +2 | 11 to 50 | 2013 |
| i2o Therapeutics | I2o Therapeutics is a biotech company that develops safe, effective oral formulations of therapies. | Biotech | Allston | Series A | $46.0M | 2023-08-28 | $90.4M | Cerity Partners Ventures, Viva BioInnovator, Sanofi Ventures +1 | 11 to 50 | 2019 |
| Luminopia | Luminopia develops digital treatments for significant neuro-visual disorders. | Biotech | Cambridge | Series A | $16.0M | 2023-06-27 | $33.1M | MassChallenge, U.S. Venture Partners, Bantam Group +2 | 11 to 50 | 2015 |
Table 1. Health care startups that raised Series A in Massachusetts, United States: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 308.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Third Arc Bio | Third Arc Bio develops multifunctional antibodies for inflammatory and immunology diseases. | Biotech | Boston | Series A | $52.0M | 2026-02-04 | $217.0M | T. Rowe Price, Cormorant Asset Management, Foresite Capital +1 | 11 to 50 | 2022 |
| 2 | AI Proteins | AI Proteins designs and engineers miniprotein therapeutics using artificial intelligence. | Artificial intelligence | Boston | Series A | $42.5M | 2025-11-19 | $80.4M | Intel Ignite, Lightchain Capital, Cobro Ventures | 11 to 50 | 2021 |
| 3 | Dash Bio | Dash Bio develops automated laboratory workflows and software to support drug development through bioanalysis services. | Artificial intelligence | Boston | Series A | $30.0M | 2026-08-03 | $47.5M | Freestyle Capital, Swift Ventures, LifeX Ventures +1 | 11 to 50 | 2024 |
| 4 | Xellar Biosystems | Xellar Biosystems analyzes drug testing and treatment data using artificial intelligence. | Artificial intelligence | Newton | Series A | $29.5M | 2026-06-30 | $93.2M | Legend Capital, Tiantu Capital, Zhengxuan Investment +1 | 11 to 50 | 2022 |
| 5 | Coral Care | Coral Care connects families with licensed speech, occupational, and physical therapists through a pediatric therapy platform. | Health care | Boston | Series A | $13.0M | 2026-02-23 | $19.5M | Hustle Fund, Reach Capital, AlleyCorp +2 | 11 to 50 | 2023 |
| 6 | Remedium Bio | Remedium Bio develops gene therapy treatments for various diseases. | Biotech | Needham | Series A | $10.0M | 2026-08-10 | $13.8M | National Science Foundation, MicroVentures, Longevitytech.fund +1 | 11 to 50 | 2020 |
| 7 | FamilyWell Health | FamilyWell Health provides integrated mental health services for pregnant and postpartum patients. | Health care | Boston | Series A | $8.0M | 2025-11-18 | $13.3M | .406 Ventures, GreyMatter, Springboard Enterprises +1 | 11 to 50 | 2022 |
| 8 | InStockRx | InStockRx connects licensed pharmacies to buy and sell inventory with each other. | Commerce | Boston | Series A | $5.0M | 2026-07-01 | $5.1M | Techstars | 1 to 10 | 2020 |
| 9 | EnVision Endoscopy | EnVision Endoscopy supplies medical devices and solutions used in endoscopic surgeries. | Health care | Lowell | Series A | $500K | 2026-03-30 | $3.9M | MassChallenge, National Science Foundation, MassVentures +1 | 1 to 10 | 2018 |
Table 2. Health care startups that raised Series A in Massachusetts, United States: the 9 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | MassChallenge | Startup accelerator | Boston, United States | 9 | 3% | 1 | EnVision Endoscopy |
| 2 | National Science Foundation | Entrepreneurship program | Alexandria, United States | 5 | 2% | 2 | Remedium Bio, EnVision Endoscopy |
| 3 | Y Combinator | Startup accelerator | Mountain View, United States | 5 | 2% | ||
| 4 | MassVentures | Venture capital firm | Boston, United States | 4 | 1% | 1 | EnVision Endoscopy |
| 5 | .406 Ventures | Venture capital firm | Boston, United States | 4 | 1% | 1 | FamilyWell Health |
| 6 | Social Starts | Micro VC fund | San Francisco, United States | 4 | 1% | ||
| 7 | Google Ventures | Corporate venture arm | San Francisco, United States | 4 | 1% | ||
| 8 | Polaris Partners | Private equity firm | Boston, United States | 4 | 1% | ||
| 9 | Alumni Ventures | Angel group | Manchester, United States | 4 | 1% | ||
| 10 | Techstars | Startup accelerator | New York, United States | 3 | 1% | 1 | InStockRx |
| 11 | Invus | Private equity firm | New York, United States | 3 | 1% | ||
| 12 | Alexandria Venture Investments | Venture capital firm | Pasadena, United States | 3 | 1% | ||
| 13 | AlleyCorp | Startup incubator | New York, United States | 2 | 1% | 1 | Coral Care |
| 14 | GreyMatter | Venture capital firm | New York, United States | 2 | 1% | 2 | Coral Care, FamilyWell Health |
| 15 | Foresite Capital | Private equity firm | San Francisco, United States | 2 | 1% | 1 | Third Arc Bio |
Table 3. Health care startups that raised Series A in Massachusetts, United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Biotech | 196 | 64% | $10.1B |
| Software | 64 | 21% | $1.5B |
| Artificial intelligence | 34 | 11% | $945.7M |
| Hardware | 21 | 7% | $329.1M |
| Commerce | 7 | 2% | $45.6M |
| Fintech | 7 | 2% | $107.3M |
| Education | 5 | 2% | $33.7M |
| Cybersecurity | 1 | 0% | $3.2M |
| Energy | 1 | 0% |
Table 4. Health care startups that raised Series A in Massachusetts, United States by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series A | 308 | 100% | $20.0M |
Table 5. Health care startups that raised Series A in Massachusetts, United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 6. Health care startups that raised Series A in Massachusetts, United States by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 1 | 3% | $11.5M |
| October 2026 | 1 | 3% | $30.0M |
| September 2026 | 4 | 13% | $307.3M |
| August 2026 | 3 | 10% | $70.0M |
| July 2026 | 3 | 10% | $44.0M |
| June 2026 | 3 | 10% | $59.1M |
| April 2026 | 3 | 10% | $209.0M |
| March 2026 | 3 | 10% | $59.5M |
| February 2026 | 2 | 6% | $65.0M |
| January 2026 | 4 | 13% | $167.5M |
| December 2025 | 1 | 3% | $47.5M |
| November 2025 | 3 | 10% | $140.5M |
Table 7. Health care startups that raised Series A in Massachusetts, United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 27 | 9% | $1.0B |
| 2025 | 36 | 12% | $1.6B |
| 2024 | 25 | 8% | $1.1B |
| 2023 | 27 | 9% | $1.4B |
| 2022 | 33 | 11% | $1.0B |
| 2021 | 37 | 12% | $1.2B |
Table 8. Health care startups that raised Series A in Massachusetts, United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 27 | 9% |
| 2020 to 2022 | 83 | 27% |
| 2015 to 2019 | 101 | 33% |
| 2010 to 2014 | 55 | 18% |
| Before 2010 | 39 | 13% |
Table 9. Health care startups that raised Series A in Massachusetts, United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 93 | 30% |
| 11 to 50 | 176 | 58% |
| 51 to 100 | 19 | 6% |
| 101 to 250 | 13 | 4% |
| 251 to 500 | 2 | 1% |
| 501 to 1,000 | 2 | 1% |
| 10,001 or more | 1 | 0% |
Table 10. Health care startups that raised Series A in Massachusetts, United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its most recent funding round is Series A and its headquarters is in Massachusetts, United States. On 16 November 2026 that is 308 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 30 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 308 rows: 32 have no round amount, 0 no city and 41 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in Massachusetts, United States whose last round is Series A are on the list?
- 308, in the file dated 16 November 2026. 31 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 308 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.